Endocrinology, Vol 137, 2001-2011, Copyright © 1996 by Endocrine Society

ARTICLES

Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements

A Staal, AJ Van Wijnen, RK Desai, HA Pols, JC Birkenhager, HF Deluca, DT Denhardt, JL Stein, JP Van Leeuwen, GS Stein and JB Lian
Department of Internal Medicine III, Erasmus University Medical School, Rotterdam, The Netherlands.

Osteocalcin and osteopontin are noncollagenous proteins secreted by osteoblasts and regulated by a complex interplay of systemic and locally produced factors, including growth factors and steroid hormones. We investigated the mechanism by which transforming growth factor-beta (TGF beta) inhibits 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3)- enhanced expression of the osteocalcin (OC) and osteopontin (OP) genes. ROS 17/2.8 cells, in which both genes are expressed, were transfected with reporter constructs driven by native (i.e. wild-type) rat OC and mouse OP promoters. TGF beta abrogated the 1,25-(OH)2D3 enhanced transcription of both the OC and OP genes. The inhibitory TGF beta response for each requires vitamin D response element (VDRE) sequences, although there are additional contributions from proximal basal regulatory elements. These transcriptional effects were further investigated for contribution of the trans-activating factors, which interact with OC and OP VDREs, involving the vitamin D receptor (VDR) and retinoid X receptor (RXR). Gel mobility shift assays show that TGF beta significantly reduces induction of the heterodimers VDR/RXR complexes in 1,25-(OH)2D3-treated ROS 17/2.8 cells. However, Western blot and ligand binding analysis reveal that TGF beta does not affect nuclear availability of the VDR. We also show that activator protein-1 activity is up-regulated by TGF beta; thus, activator protein-1 binding sites in the OC promoter may potentially contribute to inhibitory effects of TGF beta on basal transcription. Our studies demonstrate that the inhibitory action of TGF beta on the 1,25-(OH)2D3 enhancement of OC and OP transcription in osteoblastic cells results from modulations of protein-DNA interactions at the OC and OP VDRE, which cannot be accounted for by changes in VDR protein levels. As OC and OP participate in bone turnover, our results provide insight into the contributions of TGF beta and 1,25-(OH)2D3 to VDR-mediated gene regulatory mechanism operative in bone formation and/or resorption events.

This article has been cited by other articles:

				J. A. Fretz, L. A. Zella, S. Kim, N. K. Shevde, and J. W. Pike 1,25-Dihydroxyvitamin D3 Regulates the Expression of Low-Density Lipoprotein Receptor-Related Protein 5 via Deoxyribonucleic Acid Sequence Elements Located Downstream of the Start Site of Transcription Mol. Endocrinol., September 1, 2006; 20(9): 2215 - 2230. [Abstract] [Full Text] [PDF]

				K. Janssens, P. ten Dijke, S. Janssens, and W. Van Hul Transforming Growth Factor-{beta}1 to the Bone Endocr. Rev., October 1, 2005; 26(6): 743 - 774. [Abstract] [Full Text] [PDF]

				H. Du, G. S. Daftary, S. I. Lalwani, and H. S. Taylor Direct Regulation of HOXA10 by 1,25-(OH)2D3 in Human Myelomonocytic Cells and Human Endometrial Stromal Cells Mol. Endocrinol., September 1, 2005; 19(9): 2222 - 2233. [Abstract] [Full Text] [PDF]

				M. Galindo, J. Pratap, D. W. Young, H. Hovhannisyan, H.-J. Im, J.-Y. Choi, J. B. Lian, J. L. Stein, G. S. Stein, and A. J. van Wijnen The Bone-specific Expression of Runx2 Oscillates during the Cell Cycle to Support a G1-related Antiproliferative Function in Osteoblasts J. Biol. Chem., May 27, 2005; 280(21): 20274 - 20285. [Abstract] [Full Text] [PDF]

				S. Roman-Roman, D.-L. Shi, V. Stiot, E. Hay, B. Vayssiere, T. Garcia, R. Baron, and G. Rawadi Murine Frizzled-1 Behaves as an Antagonist of the Canonical Wnt/{beta}-Catenin Signaling J. Biol. Chem., February 13, 2004; 279(7): 5725 - 5733. [Abstract] [Full Text] [PDF]

				L. P. Zanello and A. W. Norman Rapid modulation of osteoblast ion channel responses by 1{alpha},25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor PNAS, February 10, 2004; 101(6): 1589 - 1594. [Abstract] [Full Text] [PDF]

				Y. Yanagi, M. Suzawa, M. Kawabata, K. Miyazono, J. Yanagisawa, and S. Kato Positive and Negative Modulation of Vitamin D Receptor Function by Transforming Growth Factor-beta Signaling through Smad Proteins J. Biol. Chem., May 7, 1999; 274(19): 12971 - 12974. [Abstract] [Full Text] [PDF]

				A. Takeshita, K. Imai, S. Kato, S. Kitano, and S. Hanazawa 1alpha ,25-Dehydroxyvitamin D3 Synergism toward Transforming Growth Factor-beta 1-induced AP-1 Transcriptional Activity in Mouse Osteoblastic Cells via Its Nuclear Receptor J. Biol. Chem., June 12, 1998; 273(24): 14738 - 14744. [Abstract] [Full Text] [PDF]